Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02180672 · ClinicalTrials.gov registry record · Phase 3
Steroids for Pediatric Apnea Research in Kids
A Phase 3 study, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- Phase 3
- Development phase
- 211
- Enrollment target
NCT02180672 is a Phase 3 study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 211 participants.
The verdict
NCT02180672, a Phase 3 study, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 211 participants
- Enrollment target
Study Summary
This double-blind, randomized controlled trial will evaluate the use of nasal corticosteroids for the treatment of the childhood obstructive sleep apnea syndrome (OSAS). Efficacy, duration of action and side-effects will be determined.
Interventions
- DRUG Placebo
- DRUG Nasal Fluticasone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 211 participants |
| Start Date | 2014-09 |
| Est. Completion | 2021-10-30 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02180672
The ClinicalTrials.gov registry entry for NCT02180672 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 211 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02180672 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02180672 about?
NCT02180672 is a clinical study titled "Steroids for Pediatric Apnea Research in Kids". This double-blind, randomized controlled trial will evaluate the use of nasal corticosteroids for the treatment of the childhood obstructive sleep apnea syndrome (OSAS). Efficacy, duration of action and side-effects will be determined.
What is the current status of trial NCT02180672?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 211 participants. The study started on 2014-09. Estimated completion is 2021-10-30.
What interventions are being tested in trial NCT02180672?
The interventions under investigation include: Placebo (DRUG), Nasal Fluticasone (DRUG).
Who is sponsoring clinical trial NCT02180672?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.